actos administrativos cff

JCVI expert warns booster vaccines will wear off

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info

Moderna is set to roll-out a new vaccine which combines the current COVID-19 shot with a flu vaccine. The two-in-one vaccine booster shot will be called mRNA-1073, according to the company. Moderna announced the first step in their novel respiratory program, which it hopes will add vaccines it is working on for respiratory syncytial virus and other respiratory diseases as an annual shot. The announcement follows Moderna’s successful rollout of its mRNA-based two-dose Covid vaccine.

CEO Stéphane Bancel said in a statement: “Today we are announcing the first step in our novel respiratory vaccine program with the development of a single dose vaccine that combines a booster against COVID-19.

“We are making progress on enrolling patients in our rare disease programs, and we are fully enrolled in our personalised cancer vaccine trial.

“We believe this is just the beginning of a new age of information-based medicines.”

The mRNA technology behind the novel vaccines have been under development for years, with the company’s jabs some of the first to be cleared for use in humans, alongside Pfizer’s. 

The cutting edge vaccines work by introducing mRNA that contain instruction to make the “spike” protein of the coronavirus. 

In response to these proteins, the body’s immune pathways are activated, aleve pain killer side effects thereby offering protection should it be exposed to the virus. 

The mRNA-1073 vaccine is one of many the company said it intends to release, which are “critical for neutralisation”. 

Modern’a announcement came as the company completed the rolling submission process for a licence for its new vaccine.

Source: Read Full Article